European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes
Journal of Neuroendocrinology · 2023-08 · 35 (8)
DOI: 10.1111/jne.13318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 14.08.2023. Verfasst von Johannes Hofland und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Section of Endocrinology, ENETS Centre of Excellence, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Pancreatic Neoplasms, Insulinoma, Gastrinoma. Die Arbeit wurde bisher 280-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This ENETS guidance paper aims to provide practical advice to clinicians for the diagnosis, treatment and follow‐up of functioning syndromes in pancreatic neuroendocrine tumours (NET). A NET‐associated functioning syndrome is defined by the presence of a clinical syndrome combined with biochemical evidence of inappropriately elevated hormonal levels. Different hormonal syndromes can be encountered in pancreatic NET patients, including insulinoma, gastrinoma as well as the rare glucagonoma, VIPoma, ACTHoma, PTHrPoma, carcinoid syndrome, calcitoninoma, GHRHoma and somatostatinoma. The recommendations provided in this paper focus on the biochemical, genetic and imaging work‐up as well as therapeutic management of the individual hormonal syndromes in well‐differentiated, grade 1‐3, functioning NET with the primary tumour originating in the pancreas, and for specific subtypes also in the duodenum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Section of Endocrinology, ENETS Centre of Excellence, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
- Pancreatic Surgery and Transplantation Unit, Pancreas Translational and Clinical Research Centre, ENETS Center of Excellence, San Raffaele Scientific Institute IRCCS, Milan, Italy.
- ENETS Centre of Excellence for Neuroendocrine and Endocrine Tumours, University Hospital Basel, Basel, Switzerland.
- Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland.
- Maimonides Biomedical Research Institute of Córdoba, Córdoba, Spain.
- Department of Cell Biology, Physiology, and Immunology, University of Córdoba, Córdoba, Spain.
ORCID-Profile: Johannes Hofland, Marie-Pierre Vullierme
Zitieren
APA
Hofland, J., Falconi, M., Christ, E., Castaño, J. P., Faggiano, A., Lamarca, A., Perren, A., Petrucci, S., Prasad, V., Ruszniewski, P., Thirlwell, C., Vullierme, M. P., Welin, S., & Bartsch, D. K. (2023). European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes. Journal of Neuroendocrinology, 35(8). https://doi.org/10.1111/jne.13318
Vancouver
Hofland J, Falconi M, Christ E, Castaño JP, Faggiano A, Lamarca A, et al. European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes. Journal of Neuroendocrinology. 2023;35(8). doi:10.1111/jne.13318
BibTeX
@article{Hofland2023,
author = {Hofland, Johannes and Falconi, Massimo and Christ, Emanuel and Castaño, Justo P and Faggiano, Antongiulio and Lamarca, Angela and Perren, Aurel and Petrucci, Simona and Prasad, Vikas and Ruszniewski, Philippe and Thirlwell, Christina and Vullierme, Marie-Pierre and Welin, Staffan and Bartsch, Detlef K},
title = {European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes},
journal = {Journal of Neuroendocrinology},
year = {2023},
volume = {35},
number = {8},
doi = {10.1111/jne.13318}
}
EUVIMED